Literature DB >> 2945436

A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors.

S S Witkin, J Hirsch, W J Ledger.   

Abstract

The possible involvement of a defect in cellular immunity in the etiology of recurrent vaginal candidiasis was explored. The mean and range of in vitro lymphocyte proliferative responses induced by mitogens were comparable in 65 patients and 36 control subjects. In contrast, Candida-directed proliferation was reduced at least 70% below the mean control value in 73% of the patients. Further analyses on selected patients demonstrated that lymphocytes of the patients responded in the normal range to Candida if incubated in the presence of control macrophages. Conversely, macrophages of patients inhibited the responses of control lymphocytes to Candida. These effects were independent of mixed leukocyte reactions between allogeneic cells. Addition of the prostaglandin inhibitors ibuprofen and indomethacin prevented macrophages of patients from inhibiting patient or control lymphocyte proliferation. In response to Candida, macrophages from some women with recurrent vaginitis produce prostaglandin, which blocks the lymphocyte proliferation response to this organism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945436     DOI: 10.1016/s0002-9378(86)80022-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  29 in total

1.  Candida albicans-derived beta-1,2-linked mannooligosaccharides induce desensitization of macrophages.

Authors:  T Jouault; C Fradin; P A Trinel; D Poulain
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women.

Authors:  D R Soll; R Galask; J Schmid; C Hanna; K Mac; B Morrow
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 3.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

Review 4.  Recurrent genital tract infection: a result of induced immunosuppression?

Authors:  C Sonnex
Journal:  Genitourin Med       Date:  1989-12

Review 5.  [Inflammations of the lower genital tract].

Authors:  N Pavić
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

6.  Immunohistochemical study of in vivo and in vitro IgA coating of candida species in vulvovaginal candidiasis.

Authors:  K Böhler; H Klade; C Poitschek; A Reinthaller
Journal:  Genitourin Med       Date:  1994-06

7.  Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections.

Authors:  P L Fidel; J L Cutright; J D Sobel
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection.

Authors:  F De Bernardis; D Adriani; R Lorenzini; E Pontieri; G Carruba; A Cassone
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.